FDA Clearance Tracker · K163154
Traxcess 7 Mini XSoft Guidewire
Last checked: Nov 19, 2026Latest source record: Dec 9, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Dec 9, 2016
Substantially Equivalent
Time to decision
29 days
Received Nov 10, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K163154
- Device name
- Traxcess 7 Mini XSoft Guidewire
- Applicant
- MicroVention, Inc.
- Applicant location
- Tistin, CA
- Received
- Nov 10, 2016
- Decided
- Dec 9, 2016
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.1330
- Specialty
- Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MOF. The earliest in FDA's data is K110584, decided Aug 22, 2011.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K163154
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for MicroVention, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K254035 · Decided Sep 3, 2026 · 261 days after receipt
Device type: Aspiration Thrombectomy Catheter (QEZ) · Cardiology
K261808 · Decided Jun 30, 2026 · 29 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
K261549 · Decided Jun 9, 2026 · 29 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.